BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 11686326)

  • 1. Oxidation of beta2-glycoprotein I (beta2GPI) by the hydroxyl radical alters phospholipid binding and modulates recognition by anti-beta2GPI autoantibodies.
    Arvieux J; Regnault V; Hachulla E; Darnige L; Berthou F; Youinou P
    Thromb Haemost; 2001 Oct; 86(4):1070-6. PubMed ID: 11686326
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structural analyses of β
    Kumar S; Wulf J; Basore K; Pozzi N
    J Thromb Haemost; 2023 Dec; 21(12):3511-3521. PubMed ID: 37536570
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A simple method to discriminate between beta2-glycoprotein I- and prothrombin-dependent lupus anticoagulants.
    Simmelink MJ; Derksen RH; Arnout J; De Groot PG
    J Thromb Haemost; 2003 Apr; 1(4):740-7. PubMed ID: 12871410
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Conformationally altered beta 2-glycoprotein I is the antigen for anti-cardiolipin autoantibodies.
    Chamley LW; Duncalf AM; Konarkowska B; Mitchell MD; Johnson PM
    Clin Exp Immunol; 1999 Mar; 115(3):571-6. PubMed ID: 10193436
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular pathophysiology of the antiphospholipid syndrome: the role of oxidative post-translational modification of beta 2 glycoprotein I.
    Passam FH; Giannakopoulos B; Mirarabshahi P; Krilis SA
    J Thromb Haemost; 2011 Jul; 9 Suppl 1():275-82. PubMed ID: 21781264
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interaction of beta2-glycoprotein I with members of the low density lipoprotein receptor family.
    Pennings MT; van Lummel M; Derksen RH; Urbanus RT; Romijn RA; Lenting PJ; de Groot PG
    J Thromb Haemost; 2006 Aug; 4(8):1680-90. PubMed ID: 16879209
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Autoimmune reactivity of IgM acquired after oxidation.
    Omersel J; Avberšek-Lužnik I; Grabnar PA; Kveder T; Rozman B; Božič B
    Redox Rep; 2011; 16(6):248-56. PubMed ID: 22195993
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Specific domain V reduction of beta-2-glycoprotein I induces protein flexibility and alters pathogenic antibody binding.
    Buchholz I; McDonnell T; Nestler P; Tharad S; Kulke M; Radziszewska A; Ripoll VM; Schmidt F; Hammer E; Toca-Herrera JL; Rahman A; Delcea M
    Sci Rep; 2021 Feb; 11(1):4542. PubMed ID: 33633190
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chemical synthesis and characterization of wild-type and biotinylated N-terminal domain 1-64 of beta2-glycoprotein I.
    Pozzi N; Banzato A; Bettin S; Bison E; Pengo V; De Filippis V
    Protein Sci; 2010 May; 19(5):1065-78. PubMed ID: 20440842
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-phospholipid autoantibodies in human diseases.
    Qin R; Wu H; Guan H; Tang C; Zheng Z; Deng C; Chen C; Zou Q; Lu L; Ma K
    Clin Immunol; 2023 Nov; 256():109803. PubMed ID: 37821073
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-β2-glycoprotein I/HLA-DR antibody in infertility.
    Ono Y; Wada S; Ota H; Fukushi Y; Tanimura K; Yoshino O; Arase H; Yamada H
    J Reprod Immunol; 2023 Aug; 158():103955. PubMed ID: 37253286
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recombinant hepatitis B surface antigen and anionic phospholipids share a binding region in the fifth domain of beta2-glycoprotein I (apolipoprotein H).
    Mehdi H; Naqvi A; Kamboh MI
    Biochim Biophys Acta; 2008 Mar; 1782(3):163-8. PubMed ID: 18230366
    [TBL] [Abstract][Full Text] [Related]  

  • 13. β2-glycoprotein I promotes the clearance of circulating mitochondria.
    Dasgupta SK; Gollamudi J; Rivera S; Poche RA; Rumbaut RE; Thiagarajan P
    PLoS One; 2024; 19(1):e0293304. PubMed ID: 38271349
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Generation of Autoantibodies in Metal-catalyzed Oxidatively Damaged DNA in Various Cancer Subjects.
    Ahmad S; Alshammari QT; Rafi Z; Rehman S; Khan MY; Faisal M; Alatar AA
    Curr Med Chem; 2024; 31(5):640-648. PubMed ID: 37138484
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Factors Affecting the Formation and Treatment of Thrombosis by Natural and Synthetic Compounds.
    Lichota A; Szewczyk EM; Gwozdzinski K
    Int J Mol Sci; 2020 Oct; 21(21):. PubMed ID: 33121005
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term treatment of rheumatoid arthritis with adalimumab.
    Murdaca G; Spanò F; Puppo F
    Open Access Rheumatol; 2013; 5():43-49. PubMed ID: 27790023
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibodies to age-β2 glycoprotein I in patients with anti-phospholipid antibody syndrome.
    Sorice M; Buttari B; Capozzi A; Profumo E; Facchiano F; Truglia S; Recalchi S; Alessandri C; Conti F; Misasi R; Valesini G; Riganò R
    Clin Exp Immunol; 2016 May; 184(2):174-82. PubMed ID: 26702877
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Free radicals and endothelial dysfunction: potential positive effects of TNF-α inhibitors.
    Murdaca G; Spanò F; Cagnati P; Puppo F
    Redox Rep; 2013; 18(3):95-9. PubMed ID: 23676793
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oxidative stress in cardiovascular inflammation: its involvement in autoimmune responses.
    Profumo E; Buttari B; Riganò R
    Int J Inflam; 2011; 2011():295705. PubMed ID: 21755027
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antiphospholipid antibodies: paradigm in transition.
    Horstman LL; Jy W; Bidot CJ; Ahn YS; Kelley RE; Zivadinov R; Maghzi AH; Etemadifar M; Mousavi SA; Minagar A
    J Neuroinflammation; 2009 Jan; 6():3. PubMed ID: 19154576
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.